Key statistics
As of last trade Organon & Co (OGN:NYQ) traded at 19.83, -14.18% below its 52-week high of 23.10, set on Aug 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.09 |
---|---|
High | 20.09 |
Low | 19.66 |
Bid | 19.82 |
Offer | 19.83 |
Previous close | 20.18 |
Average volume | 1.68m |
---|---|
Shares outstanding | 257.47m |
Free float | 257.03m |
P/E (TTM) | 5.19 |
Market cap | 5.20bn USD |
EPS (TTM) | 3.89 USD |
Annual div (ADY) | 1.12 USD |
---|---|
Annual div yield (ADY) | 5.55% |
Div ex-date | Aug 16 2024 |
Div pay-date | Sep 12 2024 |
Data delayed at least 15 minutes, as of Sep 20 2024 15:28 BST.
More ▼
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
- Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
- Organon Reports Results for the Second Quarter Ended June 30, 2024
- Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024